A Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006 in Healthy Japanese and White Subjects

Trial Profile

A Two-Part, Randomized, Double-Blind, Placebo-Controlled, Multiple-Ascending Dose Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of E2006 in Healthy Japanese and White Subjects

Completed
Phase of Trial: Phase I

Latest Information Update: 12 Feb 2015

At a glance

  • Drugs Lemborexant (Primary)
  • Indications Insomnia
  • Focus Adverse reactions; Pharmacodynamics; Pharmacokinetics
  • Sponsors Eisai Inc
  • Most Recent Events

    • 04 Jun 2014 According to the ClinicalTrials.gov record, status changed from recruiting to completed.
    • 23 Jan 2014 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top